GlassScriptPhysician profile
Graciela Hernandez
NPI 1952547564
$20,939.66
in general payments reported to CMS, 2019-2025
44 companies · $3,765 in 2025
The $3,765 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,060 · 2022: $8,189 · 2023: $2,358 · 2024: $3,568 · 2025: $3,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,658 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,658.12 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $3,334.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $3,233.17 | 2021-2025 | Farxiga, Lokelma, Airsupra |
| Novo Nordisk INC | $3,086.01 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $1,828.88 | 2021-2025 | Evenity, Krystexxa, Repatha |
| Lilly USA, LLC | $1,373.05 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $854.31 | 2021-2025 | Freestyle Libre 3, Infinity, Id Now Instrument |
| Boehringer Ingelheim Pharmaceuticals, INC. | $758.74 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Radius Health, INC. | $748.67 | 2021-2025 | Tymlos |
| Medtronic, INC. | $721.20 | 2021-2024 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $436.31 | 2021-2025 | |
| Gilead Sciences, INC. | $435.38 | 2022-2025 | |
| Glaxosmithkline, LLC. | $422.57 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $375.91 | 2021-2025 | |
| Pfizer INC. | $277.26 | 2023-2025 | |
| Madrigal Pharmaceuticals | $269.03 | 2025 | Rezdiffra |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graciela Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.